Register now: July 22, 2015 – 2nd securPharm European Conference on the FMD

The Falsified Medicines Directive introduces a set of action-items for the pharmaceutical industry to fight against counterfeit medicines. More details will be laid down in a so-called delegated act. This act will be provided by the European Commission and will cover aspects such as the specification of the safety features as well as the modalities of verification. The adoption of this legal act is planned for mid-July 2015.

On 22th July 2015, in Frankfurt am Main you will have the opportunity to be one of the first to get informed about the consolidated content of the delegated act as well as the current state of the securPharm project. You will learn first-hand from representatives of the EU Commission, the Federal Ministry of Health and selected experts from the pharmaceutical industry, how the delegated act looks in detail and which requirements affect your company.

Please register here for the event:

Please find here the detailed agenda.

Go back